Topics

"SRSF1 mediates cytokine induced impaired imatinib sensitivity chronic" Drugs and Medication Database

22:42 EDT 3rd April 2020 | BioPortfolio

Here are the most relevant "SRSF1 mediates cytokine induced impaired imatinib sensitivity chronic" Drugs and Medications that we have found in our database.

More Information about "SRSF1 mediates cytokine induced impaired imatinib sensitivity chronic" on BioPortfolio

We have published hundreds of SRSF1 mediates cytokine induced impaired imatinib sensitivity chronic news stories on BioPortfolio along with dozens of SRSF1 mediates cytokine induced impaired imatinib sensitivity chronic Clinical Trials and PubMed Articles about SRSF1 mediates cytokine induced impaired imatinib sensitivity chronic for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of SRSF1 mediates cytokine induced impaired imatinib sensitivity chronic Companies in our database. You can also find out about relevant SRSF1 mediates cytokine induced impaired imatinib sensitivity chronic Drugs and Medications on this site too.

Showing "SRSF1 mediates cytokine induced impaired imatinib sensitivity chronic" Drugs and Medications, all 18

Probably Relevant

Imatinib mesylate [avpak]

Imatinib Mesylate Tablets These highlights do not include all the information needed to use IMATINIB MESYLATE TABLETS safely and effectively. See full prescribing information for IMATINIB MESYLATE TABLETS . IMATINIB MESYLATE tablets, for oral use Initial

Possibly Relevant

Imatinib mesylate [apotex corp]

These highlights do not include all the information needed to use IMATINIB MESYLATE TABLETS safely and effectively. See full prescribing information for IMATINIB MESYLATE TABLETS .  IMATINIB MESYLATE tablets, for oral use Initial U.S. Approval: 2001

Imatinib mesylate [american health packaging]

These highlights do not include all the information needed to use IMATINIB MESYLATE TABLETS safely and effectively. See full prescribing information for IMATINIB MESYLATE TABLETS. IMATINIB MESYLATE tablets, for oral use Initial U.S. Approval: 2001

Imatinib mesylate [west-ward pharmaceuticals corp]

These highlights do not include all the information needed to use IMATINIB MESYLATE TABLETS safely and effectively. See full prescribing information for IMATINIB MESYLATE TABLETS. IMATINIB MESYLATE tablets, for oral useInitial U.S. Approval: 2001

Imatinib mesylate [northstar rxllc]

These highlights do not include all the information needed to use IMATINIB MESYLATE TABLETS safely and effectively. See full prescribing information for IMATINIB MESYLATE TABLETS. IMATINIB MESYLATE tablets, for oral use  Initial U.S. Approval: 2001

Imatinib mesylate [sun pharmaceutical industries, inc.]

These highlights do not include all the information needed to use IMATINIB MESYLATE TABLETS safely and effectively. See full prescribing information for IMATINIB MESYLATE TABLETS. IMATINIB MESYLATE tablets, for oral use  Initial U.S. Approval: 2001

Imatinib [dr.reddy's laboratories inc]

These highlights do not include all the information needed to use IMATINIB MESYLATE TABLETS safely and effectively. See full prescribing information for IMATINIB MESYLATE TABLETS . IMATINIB MESYLATE tablets, for oral use Initial U.S. Approval: 2001

Elidel [physicians total care, inc.]

Elidel

Sutent [pfizer laboratories div pfizer inc]

These highlights do not include all the information needed to use SUTENT safely and effectively. See full prescribing information for SUTENT. SUTENT (sunitinib malate) capsules, for oral useInitial U.S. Approval: 2006

Stivarga [bayer healthcare pharmaceuticals inc.]

These highlights do not include all the information needed to use STIVARGA safely and effectively. See full prescribing information for STIVARGA.STIVARGA® (regorafenib) tablets, for oral useInitial U.S. Approval: 2012

Tasigna [novartis pharmaceuticals corporation]

These highlights do not include all the information needed to use TASIGNA safely and effectively . See full prescribing information for TASIGNA. TASIGNA (nilotinib) c apsules , for oral use Initial U.S. Approval: 2007

Thymoglobulin [genzyme corporation]

These highlights do not include all the information needed to use THYMOGLOBULIN safely and effectively. See full prescribing information for THYMOGLOBULIN. THYMOGLOBULIN (anti-thymocyte globulin [rabbit]) for intravenous use Initial U.S. Approval: 1998

Miochol e [bausch & lomb incorporated]

Miochol-E

Bosulif [pfizer laboratories div pfizer inc]

These highlights do not include all the information needed to use BOSULIF safely and effectively. See full prescribing information for BOSULIF. BOSULIF(bosutinib) tablets, for oral use Initial U.S. Approval: 2012

Imatinib mesylate [mylan institutional inc.]

These highlights do not include all the information needed to use IMATINIB MESYLATE TABLETS safely and effectively. See full prescribing information for IMATINIB MESYLATE TABLETS. IMATINIB MESYLATE tablets, for oral use Initial U.S. Approval: 2001

Imatinib mesylate [mylan pharmaceuticals inc.]

These highlights do not include all the information needed to use IMATINIB MESYLATE TABLETS safely and effectively. See full prescribing information for IMATINIB MESYLATE TABLETS. IMATINIB MESYLATE tablets, for oral use Initial U.S. Approval: 2001

Imatinib mesylate [gsms, incorporated]

IMATINIB MESYLATE TABLETS These highlights do not include all the information needed to use IMATINIB MESYLATE TABLETS safely and effectively. See full prescribing information for IMATINIB MESYLATE TABLETS. IMATINIB MESYLATE tablets, for oral use Initial U

Imatinib mesylate [teva pharmaceuticals usa, inc.]

These highlights do not include all the information needed to use IMATINIB MESYLATE TABLETS safely and effectively. See full prescribing information for IMATINIB MESYLATE TABLETS. IMATINIB MESYLATE tablets, for oral use Initial U.S. Approval: 2001



Quick Search